MagVenture Pain Therapy is a drug-free, non-surgical treatment that uses Magnetic Peripheral Nerve Stimulation (mPNS) to target specific nerves associated with chronic pain. Cleared by the FDA, it’s specifically designed to address chronic pain resulting from traumatic injuries or surgery. The therapy offers an alternative for those seeking relief without invasive procedures or medication.

One perceived initiation of chronic neuropathic pain is the loss of the inhibitory function of Alpha-Beta nerve fibers, often due to degradation or damage of the myelin sheath.  Magnetic fields pass through soft tissue unobstructed and, therefore, can be targeted directly at the alpha-beta nerve fibers.  Delivering stimulation at .2-5hz with a precise pulse-widge (240-290us) specifically activates alpha-beta nerve fibers and recruits alpha-beta fibers.  These magnetic fields induce small electrical currents in the peripheral nerves.  These currents can alter the nerve signaling pathways, either blocking the transmission of pain signals or modulating the way the brain interprets pain.  The induced currents can disrupt the abnormal pain signaling patterns often seen in chronic pain conditions.  This process is known as neuromodulation, helping to normalize nerve function and reduce the intensity or perception of pain. 

Studies report an average of 54% pain reduction after one session, with 72% relief by the third.  Clinical results suggest that patients may experience up to 87% reduction in pain by the end of treatment, often with relief lasting several weeks post-treatment. This level of efficacy makes it a promising option for chronic pain sufferers who may not have had success with other treatments. The therapy’s effectiveness varies, but many patients report significant, sustained relief.

mPNS offers numerous advantages, particularly its non-invasive, painless approach that reduces the need for opioids, helping lower potential dependence by up to 51%. Additionally, patients avoid side effects typically associated with pain medications, making it an appealing option for long-term pain management.

Yes, it’s an FDA-cleared, non-invasive treatment with minimal risks, making it a suitable option for those concerned about medication side effects or surgical risks. There’s no need for anesthesia, and patients can resume normal activities immediately.

This therapy is best suited for those with chronic pain from traumatic injuries or post-surgical complications. It’s ideal for individuals looking for a non-pharmaceutical, non-surgical approach to pain management, but specific eligibility should be discussed with a healthcare provider.

Yes, it can safely complement other pain management therapies, like physical therapy or certain medications, depending on the patient’s condition. This flexibility allows healthcare providers to tailor a holistic pain management plan.

mPNS is beneficial for chronic pain, nerve injuries, neuropathies, and musculoskeletal disorders.

Generally, no. Patients may feel mild tingling but describe it as comfortable overall.

mPNS generally has minimal to no side effects. Patients may feel a tingling sensation during treatment, but it’s typically well-tolerated without lasting discomfort.